title: Radiation therapy for unresectable pancreatic adenocarcinoma: population-based trends in utilization and survival rates in the United States.
authors: Surgery Services, VA Boston Healthcare System, West Roxbury, Massachusetts2Harvard Medical School, Boston, Massachusetts.
authors: Mia
authors: M
authors: Shapiro
authors: Harvard Medical School, Boston, Massachusetts3Dana-Farber Cancer Center, Boston, Massachusetts.
authors: Naim U
authors: NU
authors: Rashid
authors: Harvard Medical School, Boston, Massachusetts4Pathology Services, VA Boston Healthcare System, West Roxbury, Massachusetts.
authors: Qin
authors: Q
authors: Huang
authors: Harvard Medical School, Boston, Massachusetts5Radiation Therapy Services, VA Boston Healthcare System, West Roxbury, Massachusetts6Beth Israel Deaconess Medical Center, Boston, Massachusetts.
authors: Shira L
authors: SL
authors: Galper
authors: Medicine Services, VA Boston Healthcare System, West Roxbury, Massachusetts8Boston University School of Medicine, Boston, Massachusetts.
authors: Valia A
authors: VA
authors: Boosalis
authors: Surgery Services, VA Boston Healthcare System, West Roxbury, Massachusetts2Harvard Medical School, Boston, Massachusetts9Brigham and Women's Hospital, Boston, Massachusetts.
authors: Edward E
authors: EE
authors: Whang
authors: Surgery Services, VA Boston Healthcare System, West Roxbury, Massachusetts2Harvard Medical School, Boston, Massachusetts9Brigham and Women's Hospital, Boston, Massachusetts.
authors: Jason S
authors: JS
authors: Gold
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy*; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D059248:Chemoradiotherapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy*; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents